Digital Health Acquisitio... (DHACW)
Digital Health Acquisition Statistics
Share Statistics
Digital Health Acquisition has - shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | - |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | 99.99% |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -11.32 and the forward PE ratio is null. Digital Health Acquisition's PEG ratio is -0.03.
| PE Ratio | -11.32 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | -4.55 |
| P/FCF Ratio | -51.95 |
| PEG Ratio | -0.03 |
Enterprise Valuation
Digital Health Acquisition has an Enterprise Value (EV) of 54.23M.
| EV / Sales | 0 |
| EV / EBITDA | -20.91 |
| EV / EBIT | -56.37 |
| EV / FCF | -56.37 |
Financial Position
The company has a current ratio of 0, with a Debt / Equity ratio of -0.39.
| Current Ratio | 0 |
| Quick Ratio | 0 |
| Debt / Equity | -0.39 |
| Debt / EBITDA | -1.64 |
| Debt / FCF | -4.42 |
| Interest Coverage | 1.64 |
Financial Efficiency
Return on Equity is 40.18% and Return on Invested Capital is 38.55%.
| Return on Equity | 40.18% |
| Return on Assets | -322.06% |
| Return on Invested Capital | 38.55% |
| Revenue Per Employee | $- |
| Profits Per Employee | $- |
| Employee Count | undefined |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0.24, so Digital Health Acquisition's price volatility has been higher than the market average.
| Beta | 0.24 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 0.14 |
| 200-Day Moving Average | 0.08 |
| Relative Strength Index (RSI) | 55.12 |
| Average Volume (20 Days) | - |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -2.59M |
| Net Income | -4.41M |
| EBITDA | -2.59M |
| EBIT | -5.99M |
| Earnings Per Share (EPS) | -1.08 |
Balance Sheet
The company has 1.86K in cash and 4.26M in debt, giving a net cash position of -4.25M.
| Cash & Cash Equivalents | 1.86K |
| Total Debt | 4.26M |
| Net Cash | -4.25M |
| Retained Earnings | -12.82M |
| Total Assets | 1.39M |
| Working Capital | -8.97M |
Cash Flow
In the last 12 months, operating cash flow was -962.04K and capital expenditures 0, giving a free cash flow of -962.04K.
| Operating Cash Flow | -962.04K |
| Capital Expenditures | 0 |
| Free Cash Flow | -962.04K |
| FCF Per Share | -0.23 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
DHACW does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -8.83% |
| FCF Yield | -1.93% |
Analyst Forecast
Currently there are no analyst rating for DHACW.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -26.81 |
| Piotroski F-Score | 2 |